Zhang Lei portfolio

HHLR Advisors (Hillhouse) · Long-term growth, heavy in China

HHLR Advisors (Hillhouse)'s 13F filing for Q2 2026, filed with the SEC on August 14, 2026, reports $832.1M across 35 US-listed positions. The largest holding is LEGN at 20.8% of the portfolio; the ten largest make up 86%. The largest buy last quarter was VIPS ($44.4M).

Reported value
$832.1M
Positions
35
In the top 10
86%
Quarter
Q2 2026
filed Aug 14

Key facts

13F portfolio value
$832.1MQ2 2026
Positions
35
Largest holding
LEGN 20.8%
Top 10 share
86%
New positions
5since Q1 2026
Sold out
8
Filed
Aug 14, 2026
Next 13F due
Nov 16, 2026Q3 2026

Holdings as of (Q2 2026), filed with the SEC on . Changes are measured against the filing for Mar 31, 2026. Source: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304).

Prices as of .

Compared with Q1 2026, Zhang Lei opened 5 new positions (ALMR, ODTX, NTES…), added to 6, trimmed 7, sold out of 8 (ONC, Clearwater Analytics Holdings, B…).

By sector, Health Care is the largest at 21% of the reported portfolio, followed by Financials at 20%; 34% is in securities with no sector on file.

18 of the 35 positions listed have been in every one of the last 9 quarterly filings.

Zhang Lei top holdings: stocks in the Q2 2026 13F

Zhang Lei holdings, Q2 2026
#StockSectorShare of portfolioValueSharesReported pricePrice nowSince period endHeldLast quarter
1Legend Biotech CorpLEGN · SPONSORED ADSHealth Care20.8%$172.8M5.98M$28.88$16.29 43.6% down9+ qtrsNo change
2Futu Holdings LtdFUTU · SPON ADS CL AFinancials19.9%$165.8M1.77M$93.74$87.27 6.9% down9+ qtrs▲ Added 25%
3Arrivent Biopharma IncAVBP—16.4%$136.5M3.93M$34.74$11.14 67.9% down9+ qtrsNo change
4Marvell Technology IncMRVLTechnology5.83%$48.5M162.93K$297.89$146.79 50.7% down2 qtrs▼ Reduced 4.7%
5Vipshop Holdings LtdVIPS · SPONSORED ADS AConsumer Discretionary5.53%$46M3.47M$13.26$12.95 2.3% down2 qtrs▲ Added more than 10×
6PDD Holdings IncPDD · SPONSORED ADSConsumer Discretionary4.58%$38.1M500K$76.28$77.86 2.1% up9+ qtrs▼ Reduced 88%
7KE Holdings IncBEKE · SPONSORED ADSReal Estate3.87%$32.2M2.22M$14.53$18.60 28.0% up9+ qtrs▼ Reduced 48%
8Cytek Biosciences IncCTKB—3.54%$29.5M6.66M$4.43$5.68 28.1% up9+ qtrsNo change
9Alamar Biosciences IncALMR—3.11%$25.9M956.46K$27.09$30.58 12.9% up1 qtrNew
10Alibaba Group Holding LtdBABA · SPONSORED ADSConsumer Discretionary2.12%$17.7M183.93K$95.98$87.11 9.2% down9+ qtrs▼ Reduced 93%
11Odyssey Therapeutics IncODTX—1.87%$15.6M831.66K$18.71$19.54 4.4% up1 qtrNew
12Yatsen Holding LtdYSG · SPONSORED ADS—1.86%$15.5M4.89M$3.17$2.12 33.0% down9+ qtrsNo change
13Novabridge BiosciencesNBP · SPONSORED ADS—1.40%$11.7M5.98M$1.95$0.7701 60.5% down9+ qtrsNo change
14Contineum Therapeutics IncCTNM · CL A—1.32%$11M669.34K$16.39$9.54 41.8% down9+ qtrsNo change
15Maze Therapeutics IncMAZE—1.31%$10.9M366.03K$29.84$33.28 11.5% up6 qtrsNo change
16Agora IncAPI · ADS—1.01%$8.4M2.1M$3.99$3.73 6.6% down7 qtrsNo change
17Taiwan Semiconductor Manufacturing Company LtdTSM · SPONSORED ADSTechnology0.89%$7.4M15.51K$477.57$361.50 24.3% down3 qtrs▼ Reduced 0.06%
18Sagimet Biosciences IncSGMT—0.67%$5.6M724.8K$7.73$9.98 29.1% up9+ qtrsNo change
19NetEase IncNTES · SPONSORED ADSTechnology0.54%$4.5M35K$128.14$119.87 6.5% down1 qtrNew
20GE AerospaceGEIndustrials0.45%$3.8M10.04K$373.73$327.12 12.5% down9+ qtrsNo change
21Lumentum Hldgs IncLITETechnology0.34%$2.8M3.3K$858.06$554.56 35.4% down2 qtrs▲ Added 120%
22NVIDIA CorpNVDATechnology0.34%$2.8M14.05K$200.09$154.76 22.7% down2 qtrs▲ Added 113%
23Tuya IncTUYA · SPONSERED ADS—0.33%$2.8M1.56M$1.76$1.58 10.2% down9+ qtrsNo change
24Corning IncGLWTechnology0.32%$2.6M10.27K$255.43$107.34 58.0% down2 qtrs▲ Added 33%
25Coherent CorpCOHRTechnology0.30%$2.5M6.42K$394.47$209.02 47.0% down2 qtrs▲ Added 50%
26Webull CorpBULL · ORD SHS—0.24%$2M309.86K$6.52$4.83 26.0% down5 qtrs▼ Reduced 79%
27Intel CorpINTCTechnology0.24%$2M14.3K$139.63$54.25 61.1% down2 qtrs▼ Reduced 51%
28Pacific Biosciences of California IncPACB—0.19%$1.5M918.89K$1.68$1.83 8.6% up9+ qtrsNo change
29Texas Instruments IncTXNTechnology0.17%$1.4M4.8K$298.07$296.11 0.7% down1 qtrNew
30Mogu IncMOGU · SPON ADS—0.17%$1.4M847.51K$1.67$1.88 12.6% up9+ qtrsNo change
31Gossamer Bio IncGOSS—0.10%$818.7K4.97M$0.1646$10.55—9+ qtrsNo change
32Equinox Gold CorpEQXMaterials0.09%$782.5K80.5K$9.72$9.99 2.7% up4 qtrsNo change
33Zoom Communications IncZM · CL ATechnology0.09%$777.7K9.01K$86.31$92.33 7.0% up1 qtrNew
34Aligos Therapeutics IncALGS—0.05%$439.9K76.25K$5.77$1.44 75.0% down9+ qtrsNo change
35Ridgetech IncRDGT · SHS NEW—0.00%$204136$1.50$0.9610 35.9% down9+ qtrs—

Zhang Lei latest buys (Q2 2026)

  • VIPS ▲ Added more than 10×$44.4M
  • FUTU ▲ Added 25%$32.7M
  • ALMR New$25.9M
  • ODTX New$15.6M
  • NTES New$4.5M
  • LITE ▲ Added 120%$1.5M
  • NVDA ▲ Added 113%$1.5M
  • TXN New$1.4M
  • COHR ▲ Added 50%$845K
  • ZM New$777.7K

Zhang Lei latest sells (Q2 2026)

  • ONC Sold$307.2M
  • PDD ▼ Reduced 88%$279.7M
  • BABA ▼ Reduced 93%$217.7M
  • Clearwater Analytics Holdings Sold$32.3M
  • BEKE ▼ Reduced 48%$29.3M
  • BULL ▼ Reduced 79%$7.8M
  • MRVL ▼ Reduced 4.7%$2.4M
  • INTC ▼ Reduced 51%$2M
  • B Sold$1M
  • DDL Sold$911.1K

Every buy and sell in Zhang Lei's Q2 2026 13F →

By sector

Zhang Lei portfolio by sector, Q2 2026
SectorShare of portfolioValuePositions
Health Care20.8%$172.8M1
Financials19.9%$165.8M1
Consumer Discretionary12.2%$101.8M3
Technology9.07%$75.4M10
Real Estate3.87%$32.2M1
Industrials0.45%$3.8M1
Materials0.09%$782.5K1
No sector on file33.6%$279.5M17

8 quarterly filings on file for HHLR Advisors, back to Q3 2024: reported value, position counts, and every buy and sell quarter by quarter.

Filing history →All Q2 2026 13F filings →

Questions about Zhang Lei's portfolio

What stocks does Zhang Lei own?

According to HHLR Advisors' 13F filing for Q2 2026, the largest of its 35 US-listed positions are LEGN (20.8%), FUTU (19.9%), AVBP (16.4%), MRVL (5.8%) and VIPS (5.5%). A 13F shows long positions only, as of the quarter's end.

What is Zhang Lei's largest holding?

LEGN (Legend Biotech Corp), worth $172.8M at the end of Q2 2026, or 20.8% of the $832.1M HHLR Advisors reported.

What did Zhang Lei buy last quarter?

In Q2 2026, compared with the filing for Q1 2026, the largest purchases were VIPS (added, $44.4M), FUTU (added, $32.7M), ALMR (new position, $25.9M), ODTX (new position, $15.6M) and NTES (new position, $4.5M).

What did Zhang Lei sell last quarter?

In Q2 2026 the largest sales were ONC (sold out, $307.2M), PDD (reduced, $279.7M), BABA (reduced, $217.7M), Clearwater Analytics Holdings (sold out, $32.3M) and BEKE (reduced, $29.3M), against the filing for Q1 2026.

How much is Zhang Lei's portfolio worth?

HHLR Advisors reported $832.1M in 35 US-listed positions for Q2 2026, valued at the quarter's end and filed on August 14, 2026. That is the 13F portfolio only: no cash, short positions or most shares listed outside the US.

When does Zhang Lei file the next 13F?

The 13F for Q3 2026, the quarter ending September 30, 2026, was due by November 16, 2026: 45 days after the quarter ends, or the next business day. The latest filing on file here is for Q2 2026, filed on August 14, 2026.

Which sectors does Zhang Lei own?

Health Care 20.8%, Financials 19.9%, Consumer Discretionary 12.2%, Technology 9.1%, Real Estate 3.9% of the reported portfolio, with 33.6% in securities that have no sector on file here (funds, smaller companies, positions without a ticker).

How long has Zhang Lei held these stocks?

Counting consecutive quarterly filings up to Q2 2026: LEGN 9+, FUTU 9+, AVBP 9+, MRVL 2, VIPS 2, PDD 9+. “9+” means the position is in every filing looked at, so it may go back further.

Learn

Cite this page

Funkfolio, “Zhang Lei portfolio: HHLR Advisors (Hillhouse) 13F holdings (Q2 2026)”, data as of 14 August 2026. https://funkfolio.com/gurus/hillhouse

Underlying data: SEC EDGAR, Form 13F-HR of HHLR Advisors (Hillhouse) (CIK 1762304) for the period ending June 30, 2026.

Source: SEC EDGAR, Form 13F-HR for HHLR Advisors (Hillhouse) (CIK 1762304), period ending Jun 30, 2026, filed Aug 14, 2026. “Last quarter” compares share counts with the filing for Mar 31, 2026. “Reported price” is the position's reported value divided by its shares — the price the filing implies for the period end. “Price now” is from Yahoo Finance and can be delayed 15 minutes or more; “since period end” sets the two side by side and is left blank where they cannot be (1 of the 35 priced positions here: the reported price falls outside the stock's 52-week range, which points to a share split since, or the range is not known). A split small enough to stay inside that range is not caught, and dividends are not counted. Sectors are those of the ranked companies on this site; funds, smaller companies and positions without a ticker have none. “Held” counts consecutive quarterly filings the position appears in, out of the 9 looked at. A buy or sell is sized as the shares moved at the price the filing implies; a position sold out at its value in the previous filing. Filings can be 45 days old when published; this is not a live portfolio and not advice.